SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-18-039198
Filing Date
2018-07-23
Accepted
2018-07-23 08:01:15
Documents
43
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tv498184_10q.htm 10-Q 352111
2 EXHIBIT 10.4 tv498184_ex10-4.htm EX-10.4 7999
3 EXHIBIT 31.1 tv498184_ex31-1.htm EX-31.1 7108
4 EXHIBIT 31.2 tv498184_ex31-2.htm EX-31.2 7084
5 EXHIBIT 32.1 tv498184_ex32-1.htm EX-32.1 3719
6 EXHIBIT 32.2 tv498184_ex32-2.htm EX-32.2 3822
  Complete submission text file 0001144204-18-039198.txt   2001577

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT bcli-20180630.xml EX-101.INS 275067
8 XBRL TAXONOMY EXTENSION SCHEMA bcli-20180630.xsd EX-101.SCH 26714
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bcli-20180630_cal.xml EX-101.CAL 19770
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bcli-20180630_def.xml EX-101.DEF 154929
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcli-20180630_lab.xml EX-101.LAB 193366
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcli-20180630_pre.xml EX-101.PRE 171166
Mailing Address 1325 AVENUE OF AMERICAS 28TH FLOOR NEW YORK NY 10019
Business Address 1325 AVENUE OF AMERICAS 28TH FLOOR NEW YORK NY 10019 201-488-0460
BRAINSTORM CELL THERAPEUTICS INC. (Filer) CIK: 0001137883 (see all company filings)

IRS No.: 207273918 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36641 | Film No.: 18963618
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1